<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cancer_Lung.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:31 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1178005">
<meta name="Category" content="Concern">
<meta name="Article" content="Cancer_Lung">
<title>C&#225;ncer de Pulm&#243;n-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">C&#225;ncer de pulm&#243;n</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Cancer_Lung.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Eichholzer M. Ernahrung und Krebs. <em>Ther Umsch</em> 2000;57:146&#8211;51
[review in German].</li>

<li class="Ref">Le Marchand L, Murphy SP, Hankin JH, et al. Intake of flavonoids and lung
cancer. <em>J Natl Cancer Inst</em> 2000;92:154&#8211;60.</li>

<li class="Ref">Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of
lung cancer and other malignant neoplasms. <em>Am J Epidemiol</em> 1997;146:223&#8211;30.</li>

<li class="Ref">Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk
of coronary heart disease and cancer in the Seven Countries Study. <em>Arch Intern Med</em>
1995;155:381&#8211;6.</li>

<li class="Ref">Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of
human cancer cell proliferation than either &#945;-carotene or &#946;-carotene. <em>Nutr
Cancer</em> 1995;24:257&#8211;66.</li>

<li class="Ref">Giovannucci E. Tomatoes, tomato-based products, lycopene and cancer: Review of
the epidemiologic literature. <em>J Natl Cancer Inst</em> 1999;91:317&#8211;331.</li>

<li class="Ref">Giovannucci E. Tomatoes, tomato-based products, lycopene and cancer: Review of
the epidemiologic literature. <em>J Natl Cancer Inst</em> 1999;91:317&#8211;31.</li>

<li class="Ref">Sinha R, Kulldorff M, Curtin J, et al. Fried, well-done red meat and risk of
lung cancer in women (United States). <em>Cancer Causes Control</em> 1998;9:621&#8211;30.</li>

<li class="Ref">Deneco-Pellegrini H, De Stefani E, Ronco A, et al. Meat consumption and risk
of lung cancer; a case-control study from Uruguay. <em>Lung Cancer</em>
1996;14:195&#8211;205.</li>

<li class="Ref">Mohr DL, Blot WJ, Tousey PM, et al. Southern cooking and lung cancer. <em>Nutr
Cancer</em> 1999;35:34&#8211;43 [review].</li>

<li class="Ref">Wynder EL, Herbert JR, Kabat GC. Association of dietary fat and lung cancer.
<em>J Natl Cancer Inst</em> 1987;79:631&#8211;7.</li>

<li class="Ref">De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary fat and lung
cancer: a case-control study in Uruguay. <em>Cancer Causes Control</em>
1997;8:913&#8211;21.</li>

<li class="Ref">Wu Y, Zheng W, Sellers TA, et al. Dietary cholesterol, fat, and lung cancer
incidence among older women: the Iowa Women&#8217;s Health Study (United States). <em>Cancer
Causes Control</em> 1994;5:395&#8211;400.</li>

<li class="Ref">Alavanja MCR, Brown CC, Swanson C, Brownson RC. Saturated fat intake and lung
cancer risk among nonsmoking women in Missouri. <em>J Natl Cancer Inst</em>
1993;85:1906&#8211;16.</li>

<li class="Ref">Alavanja MCR, Swansons C, Brown C, Brownson R. Re: Lung cancer: another
consequence of a high-fat diet? <em>J Natl Cancer Inst</em> 1994;86:314 [letter].</li>

<li class="Ref">Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a
prospective study of 51,452 Norwegian men and women. <em>Eur J Cancer Prev</em>
1997;6:540&#8211;9.</li>

<li class="Ref">De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary fat and lung
cancer: a case-control study in Uruguay. <em>Cancer Causes Control</em>
1997;8:913&#8211;21.</li>

<li class="Ref">Hinds MW, Kolonel LN, Hankin JH, Lee J. Dietary cholesterol and lung cancer
risk in a multiethnic population in Hawaii. <em>Int J Cancer</em> 1983;32:727&#8211;32.</li>

<li class="Ref">Shekelle RB, Rossof AH, Stamler J. Dietary cholesterol and incidence of lung
cancer: the Western Electric Study. <em>Am J Epidemiol</em> 1991;134:480&#8211;4.</li>

<li class="Ref">Wu Y, Zheng W, Sellers TA, et al. Dietary cholesterol, fat, and lung cancer
incidence among older women: the Iowa Women&#8217;s Health Study (United States). <em>Cancer
Causes Control</em> 1994;5:395&#8211;400.</li>

<li class="Ref">Pierce RJ, Kune GA, Kune S, et al. Dietary and alcohol intake, smoking pattern
occupational risk, and family history in lung cancer patients: results of a case-control study
in males. <em>Nutr Cancer</em> 1989;12:237&#8211;48.</li>

<li class="Ref">Rose DP, Connolley JM. Omega-3 fatty acids as cancer chemopreventive agents.
<em>Pharmacol Ther</em> 1999;83:217&#8211;44.</li>

<li class="Ref">De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary sugar and
lung cancer: a case-control study in Uruguay. <em>Nutr Cancer</em> 1998;31:132&#8211;7.</li>

<li class="Ref">Murphy GP, Lawrence W, Lenhard RE (eds). <em>American Cancer Society Textbook
of Clinical Oncology,</em> second edition. Atlanta: American Cancer Society, Inc., 1995, 221
[review].</li>

<li class="Ref">Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco
smoke and the risk of lung cancer: a meta-analysis. <em>Lung Cancer</em>
2000;27:3&#8211;18.</li>

<li class="Ref">Murphy GP, Lawrence W, Lenhard RE (eds). <em>American Cancer Society Textbook
of Clinical Oncology,</em> second edition. Atlanta: American Cancer Society, Inc., 1995, 221
[review].</li>

<li class="Ref">Lubin JR, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis
of eight epidemiologic studies. <em>J Natl Cancer Inst</em> 1997;89:49&#8211;57.</li>

<li class="Ref">Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous
metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized,
double-blind intervention trial. <em>JAMA</em> 1988;259:1525&#8211;30.</li>

<li class="Ref">Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous
metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized,
double-blind intervention trial. <em>JAMA</em> 1988;259:1525&#8211;30.</li>

<li class="Ref">Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and
for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. <em>J Natl
Cancer Inst</em> 1996;88:1550&#8211;9.</li>

<li class="Ref">The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect
of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male
smokers. <em>N Engl J Med</em> 1994;330:1029&#8211;35.</li>

<li class="Ref">Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term
supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular
disease. <em>N Engl J Med</em> 1996;334:1145&#8211;9.</li>

<li class="Ref">Doering W von E. Antioxidant vitamins, cancer and cardiovascular disease. <em>
N Engl J Med</em> 1996;335:1065 [letter].</li>

<li class="Ref">Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture compared with
synthetic all-<em>trans</em>&#946;-carotene in human serum. <em>Am J Clin Nutr</em>
1996;63:729&#8211;34.</li>

<li class="Ref">Yeum K-J, Zhu S, Xiao S, et al. &#946;-carotene intervention trial in
premalignant gastric lesions. <em>J Am Coll Nutr</em> 1995;14:536 [Abstract 48].</li>

<li class="Ref">Johnson EJ, Krinsky NI, Russell RM. Serum response of all-<em>trans</em> and
9-<em>cis</em> isomers of &#946;-carotene in humans. <em>J Am Coll
Nutr</em>1996;15:620&#8211;4.</li>

<li class="Ref">Shekelle RB, Liu S, Raynor WJ Jr, et al. Dietary vitamin A and risk of cancer
in the Western Electric Study. <em>Lancet</em>1981;2:1185&#8211;90.</li>

<li class="Ref">Medina D. Mechanisms of selenium inhibition of tumorigenesis. <em>Adv Exp Med
Biol</em> 1986;206:465&#8211;72.</li>

<li class="Ref">Beisel WR. Single nutrients and immunity. <em>Am J Clin Nutr</em>
1982;35:417&#8211;68.</li>

<li class="Ref">Medina D, Morrison DG. Current ideas on selenium as a chemopreventative agent.
<em>Pathol Immunopathol Res</em> 1988;7:187&#8211;99.</li>

<li class="Ref">Shamberger RJ, Rukoven E, Lonfield AK, et al. Antioxidants and cancer. I.
Selenium in the blood of normals and cancer patients. <em>J Natl Cancer Inst</em>
1973;4:863&#8211;70.</li>

<li class="Ref">Burney PGJ, Comstock GW, Morris JS. Serologic precursors of cancer: serum
micronutrients and the subsequent risk of pancreatic cancer. <em>Am J Clin Nutr</em>
1989;49:895&#8211;900.</li>

<li class="Ref">Toma S, Micheletti A, Giacchero A, et al. Selenium therapy in patients with
precancerous and malignant oral cavity lesions: preliminary results. <em>Cancer Detection
Prev</em> 1991;15:491&#8211;3.</li>

<li class="Ref">Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum Selenium and risk
of cancer. <em>Lancet</em> 1983;42:130&#8211;4.</li>

<li class="Ref">Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol,
&#223;-carotene, retinol, and subsequent bladder cancer. <em>Cancer Res</em>
1989;49:6144&#8211;8.</li>

<li class="Ref">Jaskiewicz K, Marasas WF, Rossouw JE, et al. Selenium and other mineral
elements in populations at risk for esophageal cancer. <em>Cancer</em>
1988;62:2635&#8211;9.</li>

<li class="Ref">Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of
cancer among Finnish men and women. <em>J Natl Cancer Inst</em> 1990;82:864&#8211;8.</li>

<li class="Ref">Yu M-W, Horng I-S, Hsu K-H, et al. Plasma selenium levels and risk of
hepatocellular carcinoma among men with chronic hepatitis virus infection. <em>Am J
Epidemiol</em> 1999;150:367&#8211;74.</li>

<li class="Ref">Scieszka M, Danch A, Machalski M, Drozdz M. Plasma selenium concentration in
patients with stomach and colon cancer in the Upper Silesia. <em>Neoplasma</em>
1997;44:395&#8211;7.</li>

<li class="Ref">Knekt P, Marniemi J, Teppo L, et al. Is low selenium status a risk factor for
lung cancer? <em>Am J Epidemiol</em> 148:975&#8211;82.</li>

<li class="Ref">Fex G, Pettersson B, Akesson B. Low plasma selenium as a risk factor for
cancer death in middle-aged men. <em>Nutr Cancer</em> 1987;10:221&#8211;9.</li>

<li class="Ref">Salonen J, Salonen R, Lappetelainen R, et al. Risk of cancer in relation to
serum concentrations of selenium and vitamins A and E; matched case-control analysis of
prospective data. <em>BMJ</em> 1985;290:417&#8211;20.</li>

<li class="Ref">Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation
for cancer prevention in patients with carcinoma of the skin. <em>JAMA</em>
1996;276:1957&#8211;63.</li>

<li class="Ref">Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta-carotene, vitamins A
and E, selenium, and the risk of lung cancer. <em>N Engl J Med</em>
1986;315:1250&#8211;4.</li>

<li class="Ref">Eichholzer M, Stahelin HB, Gey F, et al. Prediction of male cancer mortality
by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel Study.
<em>Int J Cancer</em> 1996;66:145&#8211;50.</li>

<li class="Ref">Knekt P. Vitamin E and smoking and the risk of lung cancer. <em>Ann NY Acad
Sci</em> 1993;686:280&#8211;7; discussion 287&#8211;8.</li>

<li class="Ref">Mayne ST, Janerich DT, Greenwald P, et al. Dietary beta carotene and lung
cancer risk in U.S. nonsmokers. <em>J Natl Cancer Inst</em> 1994;86:33&#8211;8.</li>

<li class="Ref">[No authors listed]. The effect of vitamin E and beta carotene on the
incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta
Carotene Cancer Prevention Study Group. <em>N Engl J Med</em> 1994;330:1029&#8211;35.</li>

<li class="Ref">Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung
cancer with high-dose vitamin A. <em>J Clin Oncol</em> 1993;11:1216&#8211;22.</li>

<li class="Ref">van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized trial of
vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. <em>J
Natl Cancer Inst</em> 2000;92:977&#8211;86.</li>

<li class="Ref">Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of
beta-carotene and vitamin A on lung cancer and cardiovascular disease. <em>N Engl J Med</em>
1996;334:1150&#8211;5.</li>

<li class="Ref">Lissoni P, Barni S, Crispino S, et al. Endocrine and immune effects of
melatonin therapy in metastatic cancer patients. <em>Eur J Cancer Clin Oncol</em>
1989;25:789&#8211;95.</li>

<li class="Ref">Neri B, De Leonardis V, Gemelli MT, et al. Melatonin as biological response
modifier in cancer patients. <em>Anticancer Res</em> 1998;18:1329&#8211;32.</li>

<li class="Ref">Lissoni P, Barni S, Crispino S, et al. Endocrine and immune effects of
melatonin therapy in metastatic cancer patients. <em>Eur J Cancer Clin Oncol</em>
1989;25:789&#8211;95.</li>

<li class="Ref">Lissoni P, Barni S, Ardizzoia A, et al. A randomized study with the pineal
hormone melatonin versus supportive care alone in patients with brain metastases due to solid
neoplasms. <em>Cancer</em> 1994;73:699&#8211;701.</li>

<li class="Ref">Lissoni P, Barni S, Ardizzoia A, et al. Randomized study with the pineal
hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant
to a first-line chemotherapy containing cisplatin. <em>Oncology</em> 1992;49:336&#8211;9.</li>

<li class="Ref">Lissoni P, Paolorossi F, Tancini G, et al. Is there a role for melatonin in
the treatment of neoplastic cachexia? <em>Eur J Cancer</em> 1996;32A:1340&#8211;3.</li>

<li class="Ref">Lissoni P, Barni S, Tancini G, et al. A randomised study with subcutaneous
low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in
advanced solid neoplasms other than renal cancer and melanoma. <em>Br J Cancer</em>
1994;69:196&#8211;9.</li>

<li class="Ref">Lissoni P, Brivio F, Ardizzoia A, et al. Subcutaneous therapy with low-dose
interlekin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low
performance status. <em>Tumori</em> 1993;79:401&#8211;4.</li>

<li class="Ref">Aldeghi R, Lissoni P, Barni S, et al. Low-dose interlekin-2 subcutaneous
immunotherapy in association with the pineal hormone melatonin as a first-line therapy in
locally advanced or metastatic hepatocellular carcinoma. <em>Eur J Cancer</em>
1994;30A:167&#8211;70.</li>

<li class="Ref">Lissoni P, Paolorossi F, Tancini G, et al. A phase II study of tamoxifen plus
melatonin in metastatic solid tumour patients. <em>Br J Cancer</em> 1996;74:1466&#8211;8.</li>

<li class="Ref">Lissoni P, Barni S, Mandal&#224;, et al. Decreased toxicity and increased
efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour
patients with poor clinical status. <em>Eur J Cancer</em> 1999;35:1688&#8211;92.</li>

<li class="Ref">Lissoni P, Brivio O, Brivio F, et al. Adjuvant therapy with the pineal hormone
melatonin in patients with lymph node relapse due to malignant melanoma. <em>J Pineal Res</em>
1996;21:239&#8211;42.</li>

<li class="Ref">Neri B, Fiorelli C, Moroni F, et al. Modulation of human lymphoblastoid
interferon activity by melatonin in metastatic renal cell carcinoma. <em>Cancer</em>
1994;73:315&#8211;9.</li>

<li class="Ref">Lissoni P, Barni S, Ardizzoia A, et al. Randomized study with the pineal
hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant
to a first-line chemotherapy containing cisplatin. <em>Oncology</em> 1992;49:336&#8211;9.</li>

<li class="Ref">Lissoni P, Barni S, Ardizzoia A, et al. Randomized study with the pineal
hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant
to a first-line chemotherapy containing cisplatin. <em>Oncology</em> 1992;49:336&#8211;9.</li>

<li class="Ref">William Judy, personal communication.</li>

<li class="Ref">Allen JI, Bell E, Boosalis MG, et al. Association between urinary zinc
excretion and lymphocyte dysfunction in patients with lung cancer. <em>Am J Med</em>
1985:79:209&#8211;15.</li>

<li class="Ref">Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin
intake in postoperative non-small cell lung cancer patients. <em>J Surg Oncol</em>
1998;68:231&#8211;6.</li>

<li class="Ref">Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin
intake in postoperative non-small cell lung cancer patients. <em>J Surg Oncol</em>
1998;68:231&#8211;6.</li>

<li class="Ref">Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment.
<em>Altern Med Rev</em> 2000;5:4&#8211;27 [review].</li>

<li class="Ref">Kaibara N, Soejima K, Nakamura T, et al. Postoperative long-term chemotherapy
for advanced gastric cancer. <em>Jpn J Surg</em> 1976;6:54&#8211;9.</li>

<li class="Ref">Niimoto M, Hattori T, Tamada R, et al. Postoperative adjuvant
immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data
on 579 patients followed for five years. <em>Jpn J Surg</em> 1988;18:681&#8211;6.</li>

<li class="Ref">Nakazato H, Koike A, Saji S, et al. Efficacy of immunochemotherapy as adjuvant
treatment after curative resection of gastric cancer. <em>Lancet</em>
1994;343:1122&#8211;6.</li>

<li class="Ref">Ogoshi K, Satou H, Isono K, et al. Possible predictive markers of
immunotherapy in esophageal cancer: retrospective analysis of a randomized study. <em>Cancer
Invest</em> 1995;13:363&#8211;9.</li>

<li class="Ref">Hayakawa K, Mitsuhashi N, Saito Y, et al. Effect of Krestin (PSK) as adjuvant
treatment on the prognosis after radical radiotherapy in patients with non-small cell lung
cancer. <em>Anticancer Res</em> 1993;13:1815&#8211;20.</li>

<li class="Ref">Yun TK. Experimental and epidemiological evidence of the cancer-preventive
effects of <em>Panax ginseng</em> C.A. Meyer. <em>Nutr Rev</em>
1996;54(suppl):S71&#8211;81.</li>

<li class="Ref">Cha RJ, Zeng DW, Chang QS. Non-surgical treatment of small cell lung cancer
with chemo-radio-immunotherapy and traditional Chinese medicine. <em>Chung Hua Nei Ko Tsa Chih
(Chin J Intern Med)</em> 1994;33:462&#8211;6.</li>

<li class="Ref">Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric
cancer and diet in northern Kyushu, Japan. <em>Jpn J Cancer Res</em>
1988;79:1067&#8211;74.</li>

<li class="Ref">Gao YT, McLaughlin JK, Blot WJ, et al. Reduced risk of esophageal cancer
associated with green tea consumption. <em>J Natl Cancer Inst</em> 1994;86:855&#8211;8.</li>

<li class="Ref">Ji BT, Chow WH, Hsing AW, et al. Green tea consumption and the risk of
pancreatic and colorectal cancers. <em>Int J Cancer</em> 1997;70:255&#8211;8.</li>

<li class="Ref">Fujiki H. Two stages of cancer prevention with green tea. <em>J Cancer Res
Clin Oncol</em> 1999;125:589&#8211;97 [review].</li>

<li class="Ref">Ohno Y, Wakai K, Genka K, et al. Tea consumption and lung cancer risk: A
case-control study in Okinawa, Japan. <em>Jpn J Cancer Res</em> 1995;86:1027&#8211;34.</li>

<li class="Ref">Goldbohm RA, Hertog MGL, Brants HAM, et al. Consumption of black tea and
cancer risk: A prospective cohort study. <em>J Natl Cancer Inst</em>
1996;88:93&#8211;100.</li>

<li class="Ref">Heilbrun L, Nomura A, Stemmermann G. Black tea consumption and cancer risk: A
prospective study. <em>Br J Cancer</em> 1986;54:677&#8211;83.</li>

<li class="Ref">Phillips RL, Snowdon DA. Dietary relationship with fatal colorectal cancer
among Seven-Day Adventists. <em>J Natl Cancer Inst</em> 1985;74:307&#8211;17.</li>

<li class="Ref">Sun AS, Ostadal O, Ryznar V, et al. Phase I/II study of stage III and IV
non-small cell lung cancer patients taking a specific dietary supplement. <em>Nutr Cancer</em>
1999;34:62&#8211;9.</li>

<li class="Ref">Sun AS, Ostadal O, Ryznar V, et al. Phase I/II study of stage III and IV
non-small cell lung cancer patients taking a specific dietary supplement. <em>Nutr Cancer</em>
1999;34:62&#8211;9.</li>

<li class="Ref">Brinker F. The Hoxsey treatment: Cancer quackery or effective physiological
adjuvant? <em>J Naturopathic Med</em> 1996;6:9&#8211;24 [review].</li>

<li class="Ref">Brinker F. The Hoxsey treatment: Cancer quackery or effective physiological
adjuvant? <em>J Naturopathic Med</em> 1996;6:9&#8211;24 [review].</li>

<li class="Ref">Austin S, Baumgartner Dale E, DeKadt S. Long term follow-up of cancer patients
using Contreras, Hoxsey and Gerson therapies. <em>J Naturopathic Med</em>
1994;5:74&#8211;6.</li>

<li class="Ref">Austin S, Baumgartner Dale E, DeKadt S. Long term follow-up of cancer patients
using Contreras, Hoxsey and Gerson therapies. <em>J Naturopathic Med</em>
1994;5:74&#8211;6.</li>

<li class="Ref">Morita K, Kada T, Namiki M. A desmutagenic factor isolated from burdock
(<em>Arctium lappa</em> Linne). <em>Mutat Res</em> 1984;129:25&#8211;31.</li>

<li class="Ref">Belkin M, Hardy WG, Perrault A, Sato H. Swelling and vacuolization induced in
ascites tumor cells by polysaccharides from higher plants. <em>Cancer Res</em>
1959;19:1050&#8211;62.</li>

<li class="Ref">Morita K, Kada T, Namiki M. A desmutagenic factor isolated from burdock
(<em>Arctium lappa</em> Linne). <em>Mutat Res</em> 1984;129:25&#8211;31.</li>

<li class="Ref">Belkin M, Hardy WG, Perrault A, Sato H. Swelling and vacuolization induced in
ascites tumor cells by polysaccharides from higher plants. <em>Cancer Res</em>
1959;19:1050&#8211;62.</li>

<li class="Ref">Uckun FM, Chelstrom LM, Finnegan D, et al. Effective immunochemotherapy of
CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined
immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus
cyclophosphamide. <em>Blood</em> 1992;79:3116&#8211;29.</li>

<li class="Ref">Uckun FM, Manivel C, Arthur D, et al. In vivo efficacy of B43 (anti-CD19)-
pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia
in mice with severe combined immunodeficiency. <em>Blood</em> 1992;79:2201&#8211;14.</li>

<li class="Ref">Uckun FM, Chelstrom LM, Irvin JD, et al. In vivo efficacy of B43
(anti-CD19)-pokeweed antiviral protein immunotoxin against BCL&#8211;1 murine B&#8211;cell
leukemia. <em>Blood</em> 1992;79:2649&#8211;61.</li>

<li class="Ref">Gunther R, Chelstrom LM, Tuel-Ahlgren L, et al. Biotherapy for xenografted
human central nervous system leukemia in mice with severe combined immunodeficiency using B43
(anti-CD19)-pokeweed antiviral protein immunotoxin. <em>Blood</em> 1995;85:2537&#8211;45.</li>

<li class="Ref">Niwa K, Hashimoto M, Morishita S, et al. Preventive effects of <em>
Glycyrrhizae radix</em> extract on estrogen-related endometrial carcinogenesis in mice. <em>
Jpn J Cancer Res</em> 1999;90:726&#8211;32.</li>

<li class="Ref">Taylor A, McKenna GF, Burlage HM. Anticancer activity of plant extracts. <em>
Texas Rep Biol Med</em> 1956;14:538&#8211;56.</li>

<li class="Ref">McKenna GF, Taylor A. Screening plant extracts for anticancer activity. <em>
Texas Rep Biol Med</em> 1962;20:214&#8211;20.</li>

<li class="Ref">Belkin M, Hardy WG, Perrault A, Sato H. Swelling and vacuolization induced in
ascites tumor cells by polysaccharides from higher plants. <em>Cancer Res</em>
1959;19:1050&#8211;62.</li>

<li class="Ref">Kupchan SM, Karim A. Tumor inhibitors. 114. Aloe emodin: Antileukemic
principle isolated from <em>Rhamnus frangula</em>&nbsp;<em>L</em>. <em>Lloydia</em>
1976;39:223&#8211;4.</li>

<li class="Ref">Taylor A, McKenna GF, Burlage HM. Anticancer activity of plant extracts. <em>
Texas Rep Biol Med</em> 1956;14:538&#8211;56.</li>

<li class="Ref">Cordell GA, Farnsworth NR. Experimental antitumor agents from plants,
1974&#8211;76. <em>Lloydia</em> 1977;40:1&#8211;44.</li>

<li class="Ref">Stermitz FR, Larson KA, Kim DK. Some structural relationships among cytotoxic
and antitumor benzophenanthridine alkaloid derivatives. <em>J Med Chem</em>
1973;16:939&#8211;40.</li>

<li class="Ref">American Cancer Society. Hoxsey Method/Bio-Medical Center. <em>CA Cancer J
Clin</em> 1990;40:51&#8211;5.</li>

<li class="Ref">Brinker F. The Hoxsey treatment: Cancer quackery or effective physiological
adjuvant? <em>J Naturopathic Med</em> 1996;6:9&#8211;24 [review].</li>

<li class="Ref">Personal correspondence, Mildred Nelson, R.N., 1983.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cancer_Lung.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:31 GMT -->
</html>

